Engineered adenovirus can shrink lung cancer tumors
Cancer Lung Cancer adenovirus

Engineered adenovirus can shrink lung cancer tumors

Oday Abushalbaq
Oday Abushalbaq

In 10 seconds? Scientists have engineered viruses that can recognize localized and spreading cancers that are resistant to other types of therapy. The “designer viruses” were able neutralize immune defenses and attack lung cancer cells, prolonging the survival of lab mice.

What's the breakthrough? Previously, scientists have applied this kind of viral therapy in a number of cancers, however, this is considered to be a breakthrough in lung cancer. In this study, researchers have genetically modified a human adenovirus (related to the ones used in the Sputnik V COVID-19 vaccine). The modifications enabled the viruses to evade being inactivated by natural immunity, and thus they could attack cancer cells and shrink tumors in test animals. Although the result still needs to be replicated in humans, another exciting finding of the study is the prospect of being able to target metastasizing cancer cells.

Get unlimited access to our 3-min Digests and other premium features!

Choose your plan.

Sparrow Insiders

$0 (Limited Offer)
  • Receive our daily Digest in your inbox
  • Created & reviewed by real scientists
  • Preview 380+ Digests in our library
  • Upgrade for unlimited learning
  • Unsubscribe anytime
  • Subject to availability
Join our first 25k subscribers for free! Signup Progress Bar Subscribe now for free

Sparrow Unlimited

$19 / month
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now

Sparrow Unlimited

$99 / year
  • One easy payment - save 56%
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now